Volume 696; Issue 1

PharmacoEconomics & Outcomes News

Volume 696; Issue 1
3

Chemostat gets "negotiated reimbursement" in Germany

Year:
2014
Language:
english
File:
PDF, 199 KB
english, 2014
4

Spanish privatisation plan withdrawn

Year:
2014
File:
PDF, 199 KB
2014
6

Scotland give patients a greater say in end-of-life/orphan drugs

Year:
2014
Language:
english
File:
PDF, 199 KB
english, 2014
7

Lubiprostone reimbursement limitations revised in Switzerland

Year:
2014
Language:
english
File:
PDF, 199 KB
english, 2014
8

Restricting use of enzalutamide?: "far from it", says NICE

Year:
2014
Language:
english
File:
PDF, 199 KB
english, 2014
9

Costs are key for small businesses offering health insurance in US

Year:
2014
Language:
english
File:
PDF, 218 KB
english, 2014
11

Trastuzumab emtansine: cost savings from fewer AEs

Year:
2014
Language:
english
File:
PDF, 199 KB
english, 2014
12

Mobile phone intervention cost saving in diabetes

Year:
2014
Language:
english
File:
PDF, 199 KB
english, 2014
13

Sofosbuvir too expensive for developing countries, says MSF

Year:
2014
Language:
english
File:
PDF, 199 KB
english, 2014
14

Ticagrelor good value for money in ACS in Canada

Year:
2014
Language:
english
File:
PDF, 199 KB
english, 2014
15

nab-P/G vs E/G: cost effective in pancreatic cancer

Year:
2014
Language:
english
File:
PDF, 233 KB
english, 2014
16

Australian elderly vaccination programme cost effective

Year:
2014
Language:
english
File:
PDF, 219 KB
english, 2014
20

China to tackle overuse of IV infusions

Year:
2014
Language:
english
File:
PDF, 219 KB
english, 2014
24

Fluticasone/salmeterol: better asthma outcomes at higher cost

Year:
2014
Language:
english
File:
PDF, 199 KB
english, 2014
28

Addictive savings from smoking cessation with varenicline

Year:
2014
Language:
english
File:
PDF, 199 KB
english, 2014
29

Lamivudine still top choice for hep

Year:
2014
Language:
english
File:
PDF, 199 KB
english, 2014
32

Telemedicine reduces hospitalisations in nursing homes

Year:
2014
Language:
english
File:
PDF, 219 KB
english, 2014
33

NICE reviews guidance on second-line erlotinib and gefitinib .

Year:
2014
Language:
english
File:
PDF, 200 KB
english, 2014
35

Robotic sacrocolpopexy a worthy option vs laparoscopy?

Year:
2014
Language:
english
File:
PDF, 200 KB
english, 2014